시장보고서

상품코드

1605808

의약품 의료기기 결합 제품 시장 규모, 점유율, 동향, 산업 분석 리포트 : 제품 유형별, 용도별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type, Application, End user, and Region- Market Forecast, 2025 - 2034

발행일: 2024년 11월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 의약품·의료기기 결합 제품 시장 규모는 2034년까지 3,435억 9,000만 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학에 대한 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.

전 세계에서 노인 인구가 증가함에 따라 전 세계 의약품 및 의료기기 복합제 시장을 주도하고 있습니다. 노인들은 일반적으로 당뇨병, 고혈압, 관절염 등 여러 가지 만성질환을 앓고 있습니다. 약물전달과 모니터링 및 기타 지원 기능을 결합한 의약품/의료기기 복합제품은 이러한 복잡한 건강 요건을 충족시키는 데 특히 유리하므로 수요가 증가하고 있습니다. 이처럼 노인 인구 증가로 인해 시장이 확대되고 있습니다.

UN이 발표한 보고서에 따르면 전 세계 65세 이상 노인 인구는 2021년 7억 6,100만 명에서 2050년 16억 명으로 두 배 이상 증가할 것으로 예측됩니다.

당뇨병 발병률 증가로 인해 세계 의약품 및 의료기기 복합제 시장이 활성화되고 있습니다. 당뇨병을 관리하기 위해서는 지속적인 투약과 모니터링이 필요합니다. 인슐린 펌프나 지속형 혈당 측정기(CGM)와 같은 의약품-의료기기 복합제품은 약물전달과 모니터링을 하나의 장비로 통합하여 당뇨병 관리를 간소화하고 환자의 편의성을 높임으로써 수요를 촉진하고 있습니다.

약물전달 활동에 대한 투자가 증가하면서 세계 의약품 및 의료기기 복합 제품 시장이 성장하고 있습니다. 이 시장의 기업은 특정 의료 수요를 충족하는 제품을 개발하고 투자를 늘림으로써 기존 솔루션보다 더 나은 성능을 구현할 수 있습니다. 이에 따라 보다 진보된 최신 약물전달 기기에 대한 수요가 증가하고 있습니다.

제약-의료기기 복합제품 시장 보고서 하이라이트

경피 패치 부문은 비침습적이고 환자 친화적인 약물전달 솔루션에 대한 수요 증가와 함께 비침습성으로 인해 2024년 시장 점유율을 장악할 것으로 예상됩니다.

약제용출 스텐트 분야는 동맥 재협착을 방지하는 약물을 방출하여 관상동맥 질환 치료에 효과적이기 때문에 조사 기간 중 가장 높은 성장이 예상됩니다.

관상동맥 질환 및 심부전 관리를 위한 첨단 기술에 대한 절실한 수요로 인해 2024년 심혈관 질환 분야가 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.

첨단 의료 인프라, 높은 수준의 R&D 활동, 기술 혁신과 시장 진입을 지원하는 강력한 규제 프레임워크로 인해 2024년 북미가 시장을 주도할 것으로 예상됩니다. 또한 다수의 주요 제약 및 의료기기 기업이 존재한다는 점도 이 부문의 우위에 기여하고 있습니다.

아시아태평양은 헬스케어 부문 확대, 의료 기술 투자 증가, 환자 수 증가로 인해 조사 기간 중 가장 빠른 성장세를 기록할 것으로 예상됩니다.

시장 스냅숏
의약품·의료기기 결합 제품 시장의 역학
- 촉진요인과 기회
  - 당뇨병의 이환율 증가가 시장을 촉진
  - 전 세계에서의 고령자 인구의 증가에 의한 시장의 확대
- 억제요인과 과제
  - 복잡한 규제 환경이 의약품·의료기기 결합 제품 시장의 성장을 억제
PESTEL 분석
의약품·의료기기 결합 제품 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 의약품·의료기기 결합 제품 시장 : 유형별

주요 조사 결과
서론
약제용출스텐트
주입 펌프
흡입기
정형외과용 복합 제품
창상관리 복합 제품
광역학요법 기기
경피패치
항균 카테터
기타

제6장 세계의 의약품·의료기기 결합 제품 시장 : 용도별

주요 조사 결과
서론
심혈관질환
당뇨병
호흡기 문제
암치료
기타

제7장 세계의 의약품·의료기기 결합 제품 시장 : 최종사용자별

주요 조사 결과
서론
병원
외래 수술 센터
기타

제8장 세계의 의약품·의료기기 결합 제품 시장 : 지역별

주요 조사 결과
서론
- 의약품·의료기기 결합 제품 시장 평가 : 지역별, 2020-2034년
북미
- 북미 : 유형별, 2020-2034년
- 북미 : 용도별, 2020-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
유럽
- 유럽 : 유형별, 2020-2034
- 유럽 : 용도별, 2020-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 유형별, 2020-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 아시아태평양 : 최종사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 중동 및 아프리카 : 최종사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

확대와 인수 분석
- 확대
- 인수
제휴/협업/합의/공개

제10장 기업 개요

Abbott
Becton, Dickinson and Company
Boston Scientific Corporation
Medtronic
Novartis AG
Sensely, Inc.
Stryker
Teleflex Incorporated
Terumo Medical Corporation
Viatris Inc.
Hovione

KSA 24.12.18

The global drug device combination products market size is expected to reach USD 343.59 billion by 2034, according to a new study by Polaris Market Research. The report "Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type (Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others), Application, End user, and Region-Market Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising geriatric population across the globe is driving the global drug device combination products market. Elderly individuals commonly have several chronic ailments like diabetes, hypertension, and arthritis. Drug-device combination products that combine medication delivery with monitoring or other supportive functions are especially advantageous for addressing these intricate health requirements, thus increasing the need. Thus, the growing geriatric population is expanding the market. For instance,

According to a report published by the United Nations, the number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050.

The global market for drug-device combination products is being fueled by the rising incidence of diabetes. Managing diabetes involves continuous medication and monitoring. Drug-device combination products, like insulin pumps or continuous glucose monitors (CGMs), streamline diabetes management by integrating drug delivery and monitoring into one device, increasing convenience for the patient and thereby boosting demand.

The rising investments in drug delivery activities are propelling the global drug device combination products market. Companies in the market are able to create products that cater to specific medical needs and deliver better performance than current solutions with increased investment. This drives the need for more advanced and up-to-date drug delivery devices.

Drug Device Combination Products Market Report Highlights

The transdermal patches segment dominated the market share in 2024 due to their non-invasive nature, which aligns with the rising demand for minimally invasive and patient-friendly drug delivery solutions.

Drug eluting stents segment is anticipated to witness the highest growth over the study period, due to their effectiveness in treating coronary artery disease by releasing medications that prevent restenosis of the artery.

Cardiovascular disorders segment accounted for the largest market share in 2024, owing to the critical need for advanced technologies for managing coronary artery disease and heart failure.

North America dominated the market in 2024 due to the advanced healthcare infrastructure, high levels of research and development activity, and strong regulatory frameworks that support innovation and market entry. Additionally, the presence of numerous leading pharmaceutical and medical device companies contributed to the segment's dominance.

Asia Pacific is projected to register the fastest growth over the study period, attributable to the expanding healthcare sector, increasing investments in medical technology, and rising patient populations.

The global players include Abbott; Becton, Dickinson and Company; Boston Scientific Corporation; Medtronic; Novartis AG; Sensely, Inc.; Stryker; Teleflex Incorporated; Terumo Medical Corporation; Viatris Inc.; and Hovione.

Polaris Market Research has segmented the drug device combination products market report based on type, application, End user, and region.

By Type Outlook (Revenue - USD Billion, 2020 - 2034)

Drug Eluting Stents
Infusion Pumps
Inhalers
Orthopedic Combination Products
Wound Care Combination Products
Photodynamic Therapy Devices
Transdermal Patches
Antimicrobial Catheters
Others

By Application Outlook (Revenue - USD Billion, 2020 - 2034)

Cardiovascular Disorder
Diabetes
Respiratory Problems
Cancer Treatment
Others

By End user Outlook (Revenue - USD Billion, 2020 - 2034)

Hospitals
Ambulatory Surgical Centers
Others

By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Drug Device Combination Products Market Insights

4.1. Drug Device Combination Products Market - Market Snapshot
4.2. Drug Device Combination Products Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing prevalence of diabetes is driving the market.
  - 4.2.1.2. Growing geriatric population worldwide propels the market.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Complex regulatory environment is hindering the drug device combination products market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Drug Device Combination Products Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Drug Device Combination Products Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
5.3. Drug Eluting Stents
- 5.3.1. Global Drug Device Combination Products Market, by Drug Eluting Stents, by Region, 2020-2034 (USD Billion)
5.4. Infusion Pumps
- 5.4.1. Global Drug Device Combination Products Market, by Infusion Pumps, by Region, 2020-2034 (USD Billion)
5.5. Inhalers
- 5.5.1. Global Drug Device Combination Products Market, by Inhalers, by Region, 2020-2034 (USD Billion)
5.6. Orthopedic Combination Products
- 5.6.1. Global Drug Device Combination Products Market, by Orthopedic Combination Products, by Region, 2020-2034 (USD Billion)
5.7. Wound Care Combination Products
- 5.7.1. Global Drug Device Combination Products Market, by Wound Care Combination Products, by Region, 2020-2034 (USD Billion)
5.8. Photodynamic Therapy Device
- 5.8.1. Global Drug Device Combination Products Market, by Photodynamic Therapy Device, by Region, 2020-2034 (USD Billion)
5.9. Transdermal Patches
- 5.9.1. Global Drug Device Combination Products Market, by Transdermal Patches, by Region, 2020-2034 (USD Billion)
5.10. Antimicrobial Catheters
- 5.10.1. Global Drug Device Combination Products Market, by Antimicrobial Catheters, by Region, 2020-2034 (USD Billion)
5.11. Other
- 5.11.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Drug Device Combination Products Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
6.3. Cardiovascular Disorder
- 6.3.1. Global Drug Device Combination Products Market, by Cardiovascular Disorder, by Region, 2020-2034 (USD Billion)
6.4. Diabetes
- 6.4.1. Global Drug Device Combination Products Market, by Diabetes, by Region, 2020-2034 (USD Billion)
6.5. Respiratory Problems
- 6.5.1. Global Drug Device Combination Products Market, by Respiratory Problems, by Region, 2020-2034 (USD Billion)
6.6. Cancer Treatment
- 6.6.1. Global Drug Device Combination Products Market, by Cancer Treatment, by Region, 2020-2034 (USD Billion)
6.7. Other
- 6.7.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Drug Device Combination Products Market, by End-user

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Drug Device Combination Products Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Ambulatory Surgical Centers
- 7.4.1. Global Drug Device Combination Products Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
7.5. Others
- 7.5.1. Global Drug Device Combination Products Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Drug Device Combination Products Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Drug Device Combination Products Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Drug Device Combination Products Market - North America
- 8.3.1. North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.3.4. Drug Device Combination Products Market - U.S.
  - 8.3.4.1. U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.3.5. Drug Device Combination Products Market - Canada
  - 8.3.5.1. Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.4. Drug Device Combination Products Market - Europe
- 8.4.1. Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.4. Drug Device Combination Products Market - UK
  - 8.4.4.1. UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.5. Drug Device Combination Products Market - France
  - 8.4.5.1. France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.6. Drug Device Combination Products Market - Germany
  - 8.4.6.1. Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.7. Drug Device Combination Products Market - Italy
  - 8.4.7.1. Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.8. Drug Device Combination Products Market - Spain
  - 8.4.8.1. Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.9. Drug Device Combination Products Market - Netherlands
  - 8.4.9.1. Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.10. Drug Device Combination Products Market - Russia
  - 8.4.10.1. Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.11. Drug Device Combination Products Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.5. Drug Device Combination Products Market - Asia Pacific
- 8.5.1. Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.4. Drug Device Combination Products Market - China
  - 8.5.4.1. China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.5. Drug Device Combination Products Market - India
  - 8.5.5.1. India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.6. Drug Device Combination Products Market - Malaysia
  - 8.5.6.1. Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.7. Drug Device Combination Products Market - Japan
  - 8.5.7.1. Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.8. Drug Device Combination Products Market - Indonesia
  - 8.5.8.1. Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.9. Drug Device Combination Products Market - South Korea
  - 8.5.9.1. South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.10. Drug Device Combination Products Market - Australia
  - 8.5.10.1. Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.11. Drug Device Combination Products Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.6. Drug Device Combination Products Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.4. Drug Device Combination Products Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.5. Drug Device Combination Products Market - UAE
  - 8.6.5.1. UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.6. Drug Device Combination Products Market - Israel
  - 8.6.6.1. Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.7. Drug Device Combination Products Market - South Africa
  - 8.6.7.1. South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.8. Drug Device Combination Products Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.7. Drug Device Combination Products Market - Latin America
- 8.7.1. Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.4. Drug Device Combination Products Market - Mexico
  - 8.7.4.1. Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.5. Drug Device Combination Products Market - Brazil
  - 8.7.5.1. Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.6. Drug Device Combination Products Market - Argentina
  - 8.7.6.1. Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.7. Drug Device Combination Products Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Becton, Dickinson and Company
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Boston Scientific Corporation
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Medtronic
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Novartis AG
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Sensely, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Stryker
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Teleflex Incorporated
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Terumo Medical Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Viatris Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Hovione
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development